Relationship of Serum Interleukin-10 and Its Genetic Variations with Ischemic Stroke in a Chinese General Population

Background and Purpose Anti-inflammatory cytokine and its genetic variations may play an important role in the process of atherosclerosis. We assessed whether serum interleukin-10 (IL-10) and its genetic variations are associated with ischemic stroke in a Chinese general population. Methods An epidemiological survey on cardiovascular diseases and their risk factors was carried in a general population in Beijing in 2005. Serum IL-10, IL-6, p-selectin, soluble intercellular adhesion molecule-1 and C-reactive protein were analyzed using ELISA kits, while three IL-10 Single Nucleotide Polymorphisms (SNP) (rs1800872, rs1554286 and rs3021094) were genotyped in 1475 participants. Results A high serum IL-10 (top tertile) was significantly associated with ischemic stroke (multivariable adjusted odds ratio (OR) =0.50; 95%CI 0.31-0.81). Rs1800872 (AA vs. AC+CC genotype, OR=1.60; 1.06-2.39), rs1554286(TT vs. CT+CC genotype, OR=1.59; 1.06-2.39), and rs3021094 (CC/CA vs. AA genotype, OR=1.64; 1.04-2.60) were all significantly associated with ischemic stroke even after controlling for age, sex, smoking, systolic blood pressure, total cholesterol, glucose, body mass index and serum IL-10. The SNP score (a summary index of these SNPs) and IL-10 (top tertile) together significantly improved the discriminative power in predicting ischemic stroke by 3.3% (95%CI: 0.2-6.4, p=0.0398) compared to predictions based on conventional risk factors alone. Conclusions The lower serum IL-10 concentration and its selected genetic variations were significantly associated with an increased likelihood of ischemic stroke in this cross-sectional study. Our results suggest that more prospective studies should be conducted to provide stronger evidence justifying the use of IL-10 and its SNPs as new biomarkers to identify a predisposition towards ischemic stroke.

[1]  Liancheng Zhao,et al.  Combination of carotid intima-media thickness and plaque for better predicting risk of ischaemic cardiovascular events , 2011, Heart.

[2]  P. O S I T I O N S T A T E M E N T,et al.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[3]  Liancheng Zhao,et al.  Relationship between -592A/C polymorphism of interleukin-10 (IL-10) gene and risk of early carotid atherosclerosis. , 2010, International journal of cardiology.

[4]  V. Uscăţescu,et al.  Interleukin-6 and interleukin-10 gene polymorphism, endothelial dysfunction, and postoperative prognosis in patients with peripheral arterial disease. , 2010, Journal of vascular surgery.

[5]  Kai-Sheng Hsieh,et al.  IL-10 polymorphisms are associated with coronary artery lesions in acute stage of Kawasaki disease. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[6]  P. Macfarlane,et al.  Genetic Variation in the Interleukin‐10 Gene Promoter and Risk of Coronary and Cerebrovascular Events , 2007, Annals of the New York Academy of Sciences.

[7]  Ying Li,et al.  Baseline pulmonary function and quality of life 9 years later in a middle-aged Chinese population. , 2005, Chest.

[8]  D. Posthuma,et al.  Heritability estimates of innate immunity: an extended twin study , 2005, Genes and Immunity.

[9]  Lin He,et al.  SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci , 2005, Cell Research.

[10]  C. Heeschen,et al.  Serum Level of the Antiinflammatory Cytokine Interleukin-10 Is an Important Prognostic Determinant in Patients With Acute Coronary Syndromes , 2003, Circulation.

[11]  M. Olivier.  A haplotype map of the human genome. , 2003, Nature.

[12]  M. Olivier.  A haplotype map of the human genome , 2003, Nature.

[13]  A. D. de Craen,et al.  Inflammation and Stroke: The Leiden 85-Plus Study , 2002, Stroke.

[14]  D. Arveiler,et al.  New polymorphisms in the interleukin‐10 gene – relationships to myocardial infarction , 2001, European journal of clinical investigation.

[15]  M. Territo,et al.  Interleukin-10 blocks atherosclerotic events in vitro and in vivo. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[16]  M. Bureau,et al.  Protective role of interleukin-10 in atherosclerosis. , 1999, Circulation research.

[17]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[18]  L. Wilkins.  An epidemiological study of cardiovascular and cardiopulmonary disease risk factors in four populations in the People's Republic of China. Baseline report from the P.R.C.-U.S.A. Collaborative Study. People's Republic of China--United States Cardiovascular and Cardiopulmonary Epidemiology Research Gr , 1992 .

[19]  P. Sharp,et al.  Spliced segments at the 5′ terminus of adenovirus 2 late mRNA* , 1977, Proceedings of the National Academy of Sciences.

[20]  W. Reznikoff,et al.  Genetic regulation: the Lac control region. , 1975, Science.

[21]  B. Cai,et al.  Association of polymorphisms in the human IL-10 and IL-18 genes with rheumatoid arthritis , 2010, Molecular Biology Reports.

[22]  Tao Li,et al.  A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn) , 2009, Cell Research.

[23]  S. Ying,et al.  Intronic microRNAs. , 2005, Biochemical and biophysical research communications.